KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsR&D In ProcessReceivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Eli Lilly (LLY) Other Gross PP&E Adjustments (2016 - 2024)

Eli Lilly's Other Gross PP&E Adjustments history spans 16 years, with the latest figure at $382.0 million for Q4 2024.

  • For Q4 2024, Other Gross PP&E Adjustments rose 19.45% year-over-year to $382.0 million; the TTM value through Dec 2024 reached $382.0 million, up 19.45%, while the annual FY2024 figure was $382.0 million, 19.45% up from the prior year.
  • Other Gross PP&E Adjustments reached $382.0 million in Q4 2024 per LLY's latest filing, up from $319.8 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $382.0 million in Q4 2024 to a low of $226.8 million in Q4 2020.
  • Average Other Gross PP&E Adjustments over 5 years is $288.8 million, with a median of $258.7 million recorded in 2021.
  • Peak YoY movement for Other Gross PP&E Adjustments: surged 162.55% in 2020, then dropped 0.81% in 2022.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $226.8 million in 2020, then rose by 14.07% to $258.7 million in 2021, then decreased by 0.81% to $256.6 million in 2022, then grew by 24.63% to $319.8 million in 2023, then grew by 19.45% to $382.0 million in 2024.
  • Per Business Quant, the three most recent readings for LLY's Other Gross PP&E Adjustments are $382.0 million (Q4 2024), $319.8 million (Q4 2023), and $256.6 million (Q4 2022).